Management Team
Tomas Leanderson
President & CEO
Born 1956
Shareholding: 52 275 shares, 25 000 personnel stock options
Tomas Leanderson has been employed at Active Biotech since 1999. He has previously carried out research at the Basel Institute for Immunology in Switzerland, worked as a lecturer in molecular immunology, and as a council researcher in cellular differentiation at Uppsala University. In 1990, Tomas Leanderson was appointed Professor of Immunology at Lund University.
Göran Forsberg
VP Investor Relations & Business Development
Born 1963
Shareholding: 3 693 shares and 5 390 personnel stock options
Göran Forsberg has been employed in Active Biotech since 1998. He has worked in the pharmaceutical industry during 20 years in different positions within KabiGen, Pharmacia and University of Adelaide, Australia.
Hans Kolam
Chief Financial Officer
Born 1951
Shareholding: 23 510 shares and 8 050 personnel stock options
Hans Kolam has worked for Active Biotech since 2000. He has more than 20 years' experience in the pharmaceuticals industry, holding different positions in Pharmacia's financial organisation, most recently as Vice President of Finance, Europe.
Helén Tuvesson
Head of Preclinical Development
Born 1962
Shareholding: 1 400 shares, 3 850 personnel stock options
Helen Tuvesson has been employed in Active Biotech since 1998. She has worked in the pharmaceutical industry during nearly 20 years in different positions within Pharmacia.